Maria E Rodríguez-Ruiz (Maria E Rodriguez, Maria E Rodriguez-Ruiz)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Squamous Cell Carcinoma

Monoclonal Antibody

Radiation Induced

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, Sandra Sanchez-Gregorio, Gabriel Gomis, Carlos Luri-Rey, Rafael Martinez-Monge, Beatrice Pinci, Karmele Valencia, Belen Palencia, Benigno Barbes, Elixabet Bolaños, Arantza Azpilikueta, Marina Garcia-Cardosa, Javier Burguete, Iñaki Eguren, Eneko Garate-Soraluze, Pedro Berraondo, Jose-Luis Perez-Gracia, Carlos E De Andrea, Maria E Rodríguez-Ruiz, Ignacio Melero Bermejo
Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, Berta Segura-Collar, Juliana Manosalva, Diego Megías, Carlos E De Andrea, Leticia Fernández-Rubio, Aurelio Hernández-Laín, Juan M Sepúlveda-Sánchez, Maria E Rodríguez-Ruiz, Ángel Pérez-Núñez, Derek A Wainwright, Ricardo Gargini, Vicente A Torres
NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. Journal for immunotherapy of cancer 12 (8) (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, Berta Segura-Collar, Juliana Manosalva, Diego Megías, Carlos E De Andrea, Leticia Fernández-Rubio, Aurelio Hernández-Laín, Juan M Sepúlveda-Sánchez, Maria E Rodríguez-Ruiz, Ángel Pérez-Núñez, Derek A Wainwright, Ricardo Gargini, Vicente A Torres
NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. Journal for immunotherapy of cancer 12 (8) (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Maria E Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, Paloma Sánchez-Mateos, Celia Barrio-Alonso, Inmaculada Rodríguez López, Victor Diaz Pascual, Leire Arbea Moreno, Maite Alvarez, Miguel F Sanmamed, Jose Luis Perez-Gracia, Helena Escuin-Ordinas, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. Journal for immunotherapy of cancer 11 (1) (2023)
Iñaki Etxeberría, Elixabet Bolaños, Alvaro Teijeira, Saray Garasa, Alba Yanguas, Arantza Azpilikueta, William M Kavanaugh, Olga Vasiljeva, Marcia Belvin, Bruce Howng, Bryan Irving, Kimberly Tipton, James West, Li Mei, Alan J Korman, Emanuela Sega, Irene Olivera, Assunta Cirella, María Carmen Ochoa, Maria E Rodríguez-Ruiz, Ana Melero, Miguel F Sanmamed, John J Engelhardt, Ignacio Melero Bermejo
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Proceedings of the National Academy of Sciences of the United States of America 118 (26) (2021)
Ivan Marquez-Rodas, Federico Longo, Maria E Rodríguez-Ruiz, Antonio Calles, Santiago Ponce-Aix, Maria Jove, Belén Rubio-Viqueira, Jose Luis Perez-Gracia, Ana Gómez-Rueda, Miguel Martín, Mariano Ponz-Sarvisé, Rosa Álvarez, Ainara Soria-Rivas, Enrique de Miguel, Rocío Ramos-Medina, Eduardo Castañon, Pablo Gajate, Cayetano Sempere Ortega, Elisabeth Jiménez-Aguilar, Maria Angela Aznar, Aitana Calvo, Pedro P López-Casas, Salvador Martín-Algarra, Miguel Martín, Dominique Tersago, Marisol Quintero, Ignacio Melero
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. Science translational medicine 12 (565) (2021)